Grantham, Mayo, Van Otterloo & Co (GMO)’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,696
Closed -$915K 701
2025
Q4
$915K Sell
4,696
-4,181,035
-100% -$995M ﹤0.01% 525
2025
Q3
$1.18B Sell
4,185,731
-1,522,692
-27% -$388M 3.32% 7
2025
Q2
$1.25B Sell
5,708,423
-356,434
-6% -$57.6M 3.76% 4
2025
Q1
$848M Buy
6,064,857
+182,864
+3% +$29.8M 2.67% 10
2024
Q4
$980M Sell
5,881,993
-135,408
-2% -$24.1M 3.19% 6
2024
Q3
$1.03B Buy
6,017,401
+324,759
+6% +$47M 3.21% 5
2024
Q2
$804M Buy
5,692,642
+186,320
+3% +$23.1M 2.71% 8
2024
Q1
$692M Buy
5,506,322
+917,783
+20% +$105M 2.51% 9
2023
Q4
$484M Buy
4,588,539
+148,308
+3% +$16.2M 2.13% 12
2023
Q3
$470M Buy
4,440,231
+38,602
+0.9% +$4.47M 2.22% 9
2023
Q2
$524M Sell
4,401,629
-29,246
-0.7% -$3.02M 2.43% 8
2023
Q1
$412M Sell
4,430,875
-291,392
-6% -$25.6M 2.09% 9
2022
Q4
$386M Sell
4,722,267
-61,642
-1% -$4.68M 2.06% 6
2022
Q3
$292M Buy
4,783,909
+69,994
+1% +$5.12M 1.69% 13
2022
Q2
$329M Sell
4,713,915
-567,875
-11% -$41.6M 1.78% 12
2022
Q1
$437M Sell
5,281,790
-830,860
-14% -$67.3M 2.11% 12
2021
Q4
$533M Sell
6,112,650
-719,612
-11% -$67.6M 2.56% 7
2021
Q3
$595M Buy
6,832,262
+273,455
+4% +$24.2M 2.94% 4
2021
Q2
$511M Buy
6,558,807
+5,720
+0.1% +$448K 2.55% 5
2021
Q1
$460M Buy
6,553,087
+17,148
+0.3% +$1.11M 2.51% 7
2020
Q4
$423M Sell
6,535,939
-52,716
-0.8% -$3.14M 2.6% 7
2020
Q3
$393M Buy
6,588,655
+127,463
+2% +$7.24M 2.8% 6
2020
Q2
$357M Sell
6,461,192
-499,138
-7% -$26.4M 2.65% 6
2020
Q1
$336M Sell
6,960,330
-1,504,768
-18% -$77.7M 2.81% 4
2019
Q4
$448M Buy
8,465,098
+98,539
+1% +$5.42M 3% 4
2019
Q3
$460M Buy
8,366,559
+80,364
+1% +$4.44M 3.19% 3
2019
Q2
$472M Sell
8,286,195
-1,253,423
-13% -$67.8M 3.32% 3
2019
Q1
$512M Sell
9,539,618
-927,022
-9% -$47.2M 3.68% 3
2018
Q4
$473M Sell
10,466,640
-414,366
-4% -$19.9M 3.77% 3
2018
Q3
$561M Sell
10,881,006
-1,883,318
-15% -$91.5M 3.8% 3
2018
Q2
$562M Sell
12,764,324
-2,501,097
-16% -$115M 3.99% 3
2018
Q1
$698M Buy
15,265,421
+486,812
+3% +$24.2M 4.27% 3
2017
Q4
$699M Buy
14,778,609
+950,761
+7% +$46.6M 4.12% 3
2017
Q3
$669M Sell
13,827,848
-362,345
-3% -$18M 3.91% 2
2017
Q2
$711M Buy
14,190,193
+50,774
+0.4% +$2.31M 3.93% 2
2017
Q1
$631M Sell
14,139,419
-1,641,390
-10% -$68.3M 3.56% 3
2016
Q4
$607M Sell
15,780,809
-2,007,365
-11% -$78.5M 3.27% 4
2016
Q3
$699M Buy
17,788,174
+439,760
+3% +$17.9M 3.3% 4
2016
Q2
$710M Buy
17,348,414
+708,225
+4% +$28.3M 2.91% 5
2016
Q1
$681M Sell
16,640,189
-798,694
-5% -$29.6M 2.54% 8
2015
Q4
$637M Sell
17,438,883
-2,705,875
-13% -$103M 2.29% 13
2015
Q3
$728M Sell
20,144,758
-6,584,228
-25% -$253M 2.53% 12
2015
Q2
$1.08B Sell
26,728,986
-3,067,600
-10% -$133M 3.47% 7
2015
Q1
$1.29B Sell
29,796,586
-11,819,542
-28% -$512M 3.84% 6
2014
Q4
$1.87B Buy
41,616,128
+1,055,200
+3% +$42.9M 5.04% 3
2014
Q3
$1.55B Sell
40,560,928
-1,080,103
-3% -$43.7M 4.11% 5
2014
Q2
$1.69B Sell
41,641,031
-708,398
-2% -$29.1M 4.58% 2
2014
Q1
$1.73B Sell
42,349,429
-5,556,755
-12% -$212M 4.52% 3
2013
Q4
$1.83B Sell
47,906,184
-1,535,787
-3% -$52.8M 4.45% 3
2013
Q3
$1.64B Sell
49,441,971
-397,249
-0.8% -$12.9M 4.32% 4
2013
Q2
$1.53B Buy
+49,839,220
New +$1.65B 3.99% 6

Other funds holding ORCL

Grantham, Mayo, Van Otterloo & Co (GMO)'s ORCL Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Oracle (ORCL) in Q1 2026, closing a stake of 4,696 shares — an estimated $915K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ORCL in Q2 2013 and held it in 51 quarters. The position peaked at $1.87B in Q4 2014. 3,472 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Oracle position as of Q1 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 4,696 Oracle shares in Q1 2026, an estimated $915K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Oracle in Q2 2013 and held it in 51 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Oracle position peaked at $1.87B in Q4 2014.
  • 3,472 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.